Zimmer raises sales forecast despite slower knee business

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 04 Nov, 17:30 UTC

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week.

science

Sources

• T2Zimmer raises sales forecast despite slower knee businessBioPharma Dive / Healthcare Dive / MedTech Dive04 Nov, 17:30